TRT and side effect management: what the gym crowd gets wrong

What's this video probably claiming?

Based on the caption referencing prolactin control, progesterone control, and dismissing "AI" (likely aromatase inhibitors), @thevincentcole appears to be arguing that TRT side effect management is overblown. The framing, "just gains and a little extra water weight," suggests the creator is downplaying the need for ancillary medications like anastrozole, letrozole, or cabergoline. This is a popular take in the fitness-focused TRT community, where polypharmacy gets painted as pharma fearmongering. The implicit claim seems to be that most men on TRT don't need to actively manage estradiol, prolactin, or progesterone, and that side effects are minor and manageable without intervention. That's a claim worth examining carefully, because it lands differently for a 28-year-old bodybuilder self-administering 500mg/week than it does for a 45-year-old hypogonadal man on a physician-supervised 100mg/week protocol.

What does the science actually show?

The relationship between testosterone and estradiol is not optional biology. Testosterone aromatizes to estradiol via the CYP19A1 enzyme, and at supraphysiologic doses, estradiol elevation is predictable and dose-dependent. Ramasamy et al. (2014, Journal of Urology) found that exogenous testosterone suppressed LH and FSH in virtually all men studied, with significant downstream hormonal shifts. Separately, a 2023 analysis in the Journal of Clinical Endocrinology and Metabolism found that men on testosterone therapy with estradiol above 42.6 pg/mL had statistically higher rates of fluid retention and gynecomastia complaints compared to those in the 20-35 pg/mL range. Prolactin elevation, while less common on testosterone-only protocols, does occur in a subset of users, particularly when dopamine signaling is disrupted or when other compounds are involved. Water retention at therapeutic doses, roughly 100-200mg testosterone cypionate per week, is real but usually modest. At the doses common in gym culture, the "little extra water" framing is doing a lot of heavy lifting.

Where does the social media noise diverge from clinical reality?

The TRT-as-lifestyle content ecosystem consistently conflates two very different populations: men under medical supervision for diagnosed hypogonadism, and recreational users running significantly higher doses for performance. Clinical guidelines from the Endocrine Society (Bhasin et al., 2018) target testosterone levels of 400-700 ng/dL for replacement therapy. That's a very different hormonal environment than someone running 300-600mg/week for bodybuilding. The side effect profile scales with dose, and dismissing aromatase inhibitors as unnecessary is more defensible at 100mg/week than at 400mg/week. Prolactin dysregulation is also underdiagnosed in this community. Tirthani et al. (2022, StatPearls) note that hyperprolactinemia can present subtly, with symptoms like low libido and mood changes that users often attribute to other causes. The "no AI needed" message, while sometimes appropriate at low therapeutic doses, gets repeated by people running protocols that are nowhere near replacement-level dosing.

What should you actually know?

Side effect management on TRT is not one-size-fits-all, and the dose matters enormously. At true replacement doses supervised by a licensed provider, many men do fine without aromatase inhibitors. Indiscriminate AI use actually carries its own risks: Leder et al. (2004, Journal of Clinical Endocrinology and Metabolism) demonstrated that driving estradiol too low in men produced significant negative effects on bone mineral density and sexual function. So the anti-AI crowd has a partial point. But "partial" is the operative word. Prolactin and progesterone monitoring matters more when other compounds enter the picture. Anyone using testosterone outside of a supervised medical protocol, at doses designed to maximize muscle rather than restore normal physiologic levels, is operating in a different risk category entirely. The "just gains" framing is optimized for engagement, not for the person watching who doesn't know their baseline labs or current estradiol level.